Forum Institutional
Optimism despite COVID-19 impact on antimicrobial resistance
Experiences during global response to COVID-19 could help with AMR prevention. Investment needed to fix the antibiotics market and protect the world.
Lars Rebien Sorensen
1981, MSc in Forestry, Faculty of Sciences, University of Copenhagen (formerly the Royal Danish Veterinary & Agricultural University); 1983, BSc in International Economics, Copenhagen Business School. 1982, joined Enzymes Marketing, Novo Nordisk; has completed several overseas postings, including in the Middle East and the US; November 2000, President and Chief Executive Officer. Since October 2007, Adjunct Professor, Faculty of Life Sciences, University of Copenhagen. Recipient, Chevalier de l'Ordre National de la Légion d'Honneur, France (2005).
Most Popular